how many people are on a glp 1 Poll: in 8 Adults Say They've Taken GLP-1 Drug, Including 4 in 10 of Those with Diabetes and 1 in 4 of Those with Heart Disease The GLP-1 Capitals: Where Weight

Serendipity also plays a powerful role

The lawsuit alleged the pharmaceutical company brought a dangerous product to market and failed to properly warn consumers about the serious side effects of the medication

its whole logic is to sustain the fullness signal over time, not to deliver a few-week push

We have previously characterized several notable benefits through this work, including improved left ventricular performance, increased coronary perfusion to the ischemic myocardial region, diminished apoptotic death of ischemic myocytes, and reduced interstitial and perivascular fibrosis within the perfusion-restricted territory

Renal effects of DPP-4 inhibitor sitagliptin or GLP-1 receptor agonist liraglutide in overweight patients with type 2 diabetes: a 12-week, randomized, double-blind, placebo-controlled trial

My work focuses on evidence-based obesity care, including nutrition therapy, behavior change support, and clinical guidance for patients using incretin-based therapies